Similar Search Results

Vom Ursprung des Unterschieds in den Rangordnungen und Ständen der Gesellschaft

Millar, John - 1985 - 1. Aufl.

Persistent link: https://www.econbiz.de/10014268367

John Millar of Glasgow, 1735-1801 : his life and thought and his contributions to sociological analysis

Lehmann, William Christian - 1960

Persistent link: https://www.econbiz.de/10000102644

The origin of the distinction of ranks

Millar, John - 1986 - Reprint of the 4. ed., Edinburgh 1806

Persistent link: https://www.econbiz.de/10000714699

The origin of the distinction of ranks; or, an inquiry into the circumstances which give rise to influence and authority in the different members of society

Millar, John - 1806

Persistent link: https://www.econbiz.de/10001761388

Zwei Handbücher der Soziologie : eine vergleichende Besprechung

Lehmann, William C. - In: Zeitschrift für die gesamte Staatswissenschaft : ZgS 113 (1957) 4, pp. 747-760

Persistent link: https://www.econbiz.de/10002369478

Some conditions of a fruitful cultural exchange between Germany and the United States

Lehmann, William C. - In: Sociologus : journal for social anthropology 3 (1953) 1, pp. 14-28

Persistent link: https://www.econbiz.de/10002369492

Herder's contribution toward an empirical sociology and cultural anthropology

Lehmann, William C. - In: Sociologus : journal for social anthropology 10 (1960) 1, pp. 17-33

Persistent link: https://www.econbiz.de/10002369497

Sozialökologie : eine Methode der Gemeindeforschung in den Vereinigten Staaten von Amerika

Lehmann, William C. - In: Zeitschrift für die gesamte Staatswissenschaft : ZgS 109 (1953) 3, pp. 422-440

Persistent link: https://www.econbiz.de/10002369522

The origin of the distinction of ranks, or, An inquiry into the circumstances which give rise to influence and authority, in the different members of society

Millar, John - 1779 - The 3rd ed., corr. and enl

Persistent link: https://www.econbiz.de/10012350752

Cost Effectiveness of Trastuzumab in the Adjuvant Treatment of Early Breast Cancer

Millar, J.; Millward, Michael - In: PharmacoEconomics 25 (2007) 5, pp. 429-442

The results suggest that trastuzumab as adjuvant therapy for early breast cancer may be cost effective when given over either 52 or 9 weeks at current acquisition costs in Australia. However, the overall budget impact of the 52-week course is significant, and the 9-week course appears...

Persistent link: https://www.econbiz.de/10011001785